(0.02%) 5 071.63 points
(-0.11%) 38 461 points
(0.10%) 15 713 points
(-0.01%) $82.80
(0.54%) $1.662
(-0.38%) $2 329.40
(-0.48%) $27.22
(-0.46%) $911.60
(0.00%) $0.935
(0.05%) $10.99
(0.02%) $0.803
(-0.94%) $92.32
Live Chart Being Loaded With Signals
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally...
Stats | |
---|---|
Today's Volume | 3.14M |
Average Volume | 2.63M |
Market Cap | 204.71B |
EPS | $0.460 ( 2007-02-07 ) |
Last Dividend | $1.287 ( 2023-03-16 ) |
Next Dividend | $0 ( N/A ) |
P/E | 15.58 |
ATR14 | $0.0170 (0.06%) |
Volume Correlation
Roche Holding AG Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Roche Holding AG Correlation - Currency/Commodity
Roche Holding AG Financials
Annual | 2023 |
Revenue: | $60.44B |
Gross Profit: | $44.08B (72.94 %) |
EPS: | $14.39 |
Q4 | 2023 |
Revenue: | $28.94B |
Gross Profit: | $20.66B (71.39 %) |
EPS: | $5.47 |
Q2 | 2023 |
Revenue: | $29.78B |
Gross Profit: | $22.24B (74.69 %) |
EPS: | $8.93 |
Q1 | 2023 |
Revenue: | $15.31B |
Gross Profit: | $11.50B (75.11 %) |
EPS: | $4.44 |
Financial Reports:
No articles found.
Roche Holding AG Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$1.287 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.211 | 2005-02-28 |
Last Dividend | $1.287 | 2023-03-16 |
Next Dividend | $0 | N/A |
Payout Date | 2023-03-27 | |
Next Payout Date | N/A | |
# dividends | 19 | -- |
Total Paid Out | $16.76 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.79 | -- |
Div. Sustainability Score | 9.81 | |
Div.Growth Potential Score | 4.23 | |
Div. Directional Score | 7.02 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
NDBKY | Ex Dividend Junior | 2023-09-07 | Annually | 0 | 0.00% | |
CYFL | Ex Dividend Knight | 2023-09-05 | Quarterly | 0 | 0.00% | |
TBLMY | Ex Dividend Junior | 2023-07-06 | Annually | 0 | 0.00% | |
HVRRY | Ex Dividend Junior | 2023-05-04 | Annually | 0 | 0.00% | |
BDVSY | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
PDER | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
EFGXY | Ex Dividend Knight | 2023-04-25 | Annually | 0 | 0.00% | |
TXHPF | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
JTEKF | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
CBCFF | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.194 | 1.500 | 6.12 | 9.18 | [0 - 0.5] |
returnOnAssetsTTM | 0.191 | 1.200 | 3.65 | 4.37 | [0 - 0.3] |
returnOnEquityTTM | 0.618 | 1.500 | 4.25 | 6.37 | [0.1 - 1] |
payoutRatioTTM | 0.663 | -1.000 | 3.37 | -3.37 | [0 - 1] |
currentRatioTTM | 1.347 | 0.800 | 8.26 | 6.61 | [1 - 3] |
quickRatioTTM | 1.026 | 0.800 | 8.67 | 6.94 | [0.8 - 2.5] |
cashRatioTTM | 0.217 | 1.500 | 9.91 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.340 | -1.500 | 4.33 | -6.49 | [0 - 0.6] |
interestCoverageTTM | 30.48 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 29.53 | 2.00 | 0.158 | 0.315 | [0 - 30] |
freeCashFlowPerShareTTM | 21.35 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.050 | -1.500 | 5.80 | -8.70 | [0 - 2.5] |
grossProfitMarginTTM | 0.734 | 1.000 | 1.092 | 1.092 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.284 | 1.000 | 6.32 | 6.32 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.765 | 1.000 | 6.86 | 6.86 | [0.2 - 2] |
assetTurnoverTTM | 0.983 | 0.800 | 6.78 | 5.42 | [0.5 - 2] |
Total Score | 9.81 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 1.320 | 1.000 | 9.97 | 0 | [1 - 100] |
returnOnEquityTTM | 0.618 | 2.50 | 6.30 | 6.37 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 21.35 | 2.00 | 2.88 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.88 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 29.53 | 2.00 | 0.158 | 0.315 | [0 - 30] |
payoutRatioTTM | 0.663 | 1.500 | 3.37 | -3.37 | [0 - 1] |
pegRatioTTM | 0.0270 | 1.500 | -3.15 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.265 | 1.000 | 5.88 | 0 | [0.1 - 0.5] |
Total Score | 4.23 |
Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators